GGrantIndex
← Leaderboards

Rhode Island Hospital

Providence, RI

Compare ↔
$727,188,882
Total funding
690
Grants

Funding over time

peak $48.1M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$700,886,779 · 658
DOD$10,491,032 · 9
CDC$8,626,698 · 10
AHRQ$6,381,540 · 11
NSF$802,833 · 2

By mechanism

R01$364,588,245 · 208
P20$88,972,122 · 152
U01$61,449,911 · 15
R21$29,384,085 · 73
K23$22,745,551 · 35
T32$21,254,654 · 8

Investigators at Rhode Island Hospital

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Leslie Ann Daline Brick$1,368,6861 gr2Stephanie Chow Garbern$539,9871 gr3Justin Berk$487,6861 gr4Brandon Del Pozo$414,9622 gr5Prachi Bhuptani$248,3961 gr6Cynthia Esetban$232,3081 gr7Evan Anderson$192,6151 gr8Min Dong$185,0081 gr

Emerging Leaders

6–10 yrs in

1Lise E. Nigrovic$5,642,3311 gr2Francesca Beaudoin$3,928,3665 gr3Craig Thomas Lefort$3,582,3374 gr4Jin O-Uchi$2,511,2062 gr5Elizabeth Anne Samuels$2,206,1822 gr6Patrycja Marta Dubielecka-Szczerba$1,969,2151 gr7Tracy Madsen$1,919,0731 gr8Jacqueline Nesi$1,889,3402 gr

All-Time

Most funded here, all years

1Joseph J Crisco$15,739,42512 gr2Nicole R Nugent$15,130,2857 gr3Susan E Ramsey$13,686,52513 gr4Jack R Wands$12,631,3926 gr5Marina Tolou-Shams$11,910,7067 gr6Roland C Merchant$10,283,5718 gr7Christopher D. Houck$9,708,1927 gr8Megan Larin Ranney$9,316,0545 gr

Largest grants

Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2009 · DK
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2008 · DK
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$4,000,000
U01 · FY2007 · DK
The Developing Brain: Influences and Outcomes$3,950,813
UH3 · FY2020 · OD
The Developing Brain: Influences and Outcomes$3,933,025
UH3 · FY2021 · OD
A Randomized, Controlled Trial for Homocysteine$3,700,000
U01 · FY2005 · DK
The Developing Brain: Influences and Outcomes$3,508,435
UH3 · FY2019 · OD
A Randomized, Controlled Trial for Homocysteine$3,400,000
U01 · FY2004 · DK
ASSESSING THE EVOLVING IMPACT OF EARLY LIFE EXPOSURES ON CHILD PHYSICAL HEALTH AND NEURODEVELOPMENT$2,878,887
UG3 · FY2023 · OD
SEXUAL ASSAULT PREVENTION FOR MEN IN THE MILITARY$2,756,278
· FY2015 · Defense Health Agency
COBRE for Skeletal Health and Repair$2,619,017
P20 · FY2007 · RR
COBRE Center on Opioids and Overdose$2,555,339
P20 · FY2018 · GM
COBRE Center on Opioids and Overdose$2,498,628
P20 · FY2023 · GM
Translational Approaches for Pathogens of Human Significance$2,490,273
P20 · FY2025 · GM
Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE)$2,441,890
P20 · FY2022 · GM
Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE)$2,436,848
P20 · FY2023 · GM
Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE)$2,429,060
P20 · FY2024 · GM
COBRE Center on Opioids and Overdose$2,428,175
P20 · FY2019 · GM
COBRE Center on Opioids and Overdose$2,424,344
P20 · FY2024 · GM
COBRE Center on Opioids and Overdose$2,409,022
P20 · FY2021 · GM